MMP2 and Anterior polar cataract: For example, using a TGFβ-induced model of anterior subcapsular cataracts in rats, we demonstrated that cotreatment with the MMP-2/9 specific inhibitor effectively prevented anterior subcapsular cataract formation and the associated deposition of matrix [43].